| Thursday November 19th 2009
|
| 14.00-15.30
|
Symposium
Molecular pharmacology of pain
Chairperson: Basileios Kokkas (Greece)
Tissue injury and inflammation
Basileios Kokkas (Greece)
Inflammation and pain
Maria Mironidou-Tzouveleki (Greece)
Neuropeptides and pain
Dimitra Molyva (Greece)
Drugs against pain-New concepts
Paraskeyi Papaioannidou (Greece)
The symposium is organized by the 1st Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Greece
|
| 15.30-17.00
|
Symposium
Translational medicine informs treatment guidance in depression
Chairpersons: David Taylor (UK) and Katherine J Aitchison (UK)
New guidelines on depression from NICE
Ruth I Ohlsen (UK)
Clinical lessons from GENDEP for the treatment of depression
Katherine J Aitchison (UK)
Using a preclinical approach to reveal potential mechanisms of ADRs to antidepressants in adolescents
Evangelia M Tsapakis (UK)
Insights from pharmacogenetic studies of antidepressants
Laura Mandelli (Italy)
The symposium is organised by The MRC SGDP Centre, Institute of Psychiatry at King's College London, UK
|
| 17.00-17.30
|
Lecture
Chairperson: Janus K. Rybakowski (Poland)
Is "Freedom of the Will" neurobiologically possible?
Filippos Kargopoulos (Greece)
|
| 17.30-19.00
|
Symposium
New Technologies in Bipolar Disorder
Chairperson: Yanni Malliaris (UK)
Kraepelin Digitised: New Technologies for Monitoring the Course of Bipolar Disorder
Yanni Malliaris (UK)
Enhancing adherence to mood charting with an online version of the NIMH Life Chart
Daniel Lieberman (USA)
MyiMonitor.com v.1.0: A user-friendly mobile electronic diary for bipolar patients
Yanni Malliaris (UK)
Porcupines: Fine grained activity monitoring in psychiatry using accelerometer sensors
Kristof Van Laerhoven (Germany)
The symposium is organized by the Hellenic Bipolar Organization
|
| 19.00-19.30
|
Coffee break
|
| 19.30-20.00
|
Lecture
Chairperson: Nikolaos Degleris (Greece)
Bipolar mood disorder and treatment-resistant depression
Janusz K. Rybakowski (Poland)
|
| 20.00-21.30
|
Symposium (in Greek)
Addiction is a personal choice-Treatment of addiction is a collective effort
Chairperson: Panagiotis Georgakas (Greece)
The nature of addiction and drug rehabilitation
Phaedon Kaloterakis (Greece)
Addiction and guilt
Nikolaos Paraskevopoulos (Greece)
Alternative approaches of addiction and dominant scientific perspectives
Sotirios Lainas (Greece)
The primary prevention in the service of addiction
Vasilios Koutras (Greece)
The family's attitude towards addiction
Vasileios Kalampalikis (Greece)
Truth and lies about the social rehabilitation of drug addiction
Panagiotis Georgakas (Greece)
The symposium is organized by the Psychiatric Hospital of Thessaloniki
|
|
| Friday November 20th 2009
|
| 09.00-09.30
|
Lecture
Chairperson: Dimitrios Vartzopoulos (Greece)
Changes in the expenditure for psychopharmaca in the last 20 years in Greece
Sotiris Koupidis (Greece)
|
| 09.30-11.00
|
Symposium
The clinical psychopharmacology of eicosapentaenoic acid (EPA)
Chairperson: Basant K. Puri (UK) and Massimo Cocchi (Switzerland)
The structure, biosynthesis and functions of EPA: Biomolecular neuropsychiatric aspects
Sofia Tsaluchidu (Italy)
The pharmacotherapy of depression with EPA
Basant K. Puri (UK)
EPA in schizophrenia and violence
Ian H. Treasaden (UK)
EPA and the Perrin Technique: A combined approach to treating myalgic encephalomyelitis
Raymond Perrin (UK)
Running the hypothesis of a bio molecular approach to psychiatric disorder characterization and fatty acids therapeutical choices
Massimo Cocchi (Switzerland)
EPA and Huntington's chorea: treatment and associated cerebral changes
Basant K. Puri (UK)
|
| 11.00-12.30
|
Symposium
Neurobiology of trauma
Chairperson: Lefteris Lykouras (Greece)
Early neurobiological changes in childhood after traumatization
Apostolos Vourdas (Greece)
Pertinent changes in adult brain neurobiology due to trauma
Christos Tsopelas (Greece)
Psychological treatments of trauma consequences in mental health.
Ioanna Giannopoulou (Greece)
Pharmacological treatment in mental health disorders after trauma.
Athanasios Douzenis (Greece)
The symposium is organized by the Forensic Mental Health Section of the Greek Psychiatric Association
|
| 12.30-13.00
|
Coffee break
|
| 13.00-14.30
|
Symposium
How to deal with the huge comorbidity of somatic disorders in patients with severe mental disorders
Chairperson: Hans-Jürgen Möller (Germany)
The general problem of increased somatic comorbidity in bipolar patients.
Julio Bobes (Spain)
Increased metabolic and cardiovascular morbidity in patients with schizophrenia. Recommendation for diagnoses and treatment.
Dan Cohen (Netherlands)
Metabolic alterations in patients with depression and their relationship to the etiology of depressive disorders
Kail G. Kahl (Germany)
No health without mental health-Towards a holistic approach
Meni Malliori (Greece)
The EPA/EADS/ESC position statement on diabetes and cardiovascular risk in patients with severe mental disorders.
Hans-Jürgen Möller (Germany)
The symposium is organized by the European Psychiatric Association
|
| 14.30-15.30
|
Lunch Break
|
| 15.30-17.00
|
Symposium
Neurobiology of stress
Chairperson: Jerom Yesavage (USA) and Michael Sotiriou (Greece)
Effects of Sleep Apnea and APOE 4 Status on Follow-up of Veterans with PTSD from the Vietnam Conflict.
Jerom Yesavage (USA)
The mediating role of 5-HTTLPR in the background of stress vulnerability
Xenia Gonda (Hungary)
Stress in medical patients
Stavros Samolis (Greece)
Stress in special groups
Michael Sotiriou (Greece)
|
| 17.00-17.30
|
Lecture
Chairperson: Konstantinos N. Fountoulakis (Greece)
Stigma by health and mental health professionals in comorbid states
Levent Küey (Turkey)
The symposium is organized by the World Psychiatric Association
|
| 17.30-19.00
|
Symposium
Recommended Guidance on Schizophrenia
Chairpersons: Wolfgang Gaebel (Germany) and Cyril Höschl (Czech Rep)
European Treatment Guidelines for schizophrenia
Wolfgang Gaebel (Germany)
WFSBP Treatment Guidelines and the problem of evidence grading
Hans-Jürgen Möller (Germany)
Recommended Guidance beyond Guidelines
Cyril Höschl (Czech Rep)
Guidance in the ages of neuroscience
Lefteris Lykouras (Greece)
The symposium is organized by the European Psychiatric Association
|
| 19.00-19.30
|
Coffee break
|
| 19.30-20.00
|
Lecture
Chairperson: Cyril Höschl (Czech Rep)
The American Psychiatric Association Treatment Guideline for Major Depressive Disorder: Process and Content
Alan J. Gelenberg (USA)
|
| 20.00-21.30
|
SATELITE SYMPOSIUM
Agomelatine: a new era in the treatment of depression
Chairpersons: Hans-Jürgen Möller (Germany) and Konstantinos N. Fountoulakis (Greece)
Biological theory of depression in the light of new evidence
George Papageorgiou (Greece)
Circadian rhythms: strong evidence on how to approach depression
Konstantinos N. Fountoulakis (Greece)
Agomelatine: relief ensured at each and every stage of depression
Hans-Jürgen Möller (Germany
The symposium is organized by Servier
|
| 21:30
|
OPENING CEREMONY
|
|
| Saturday November 21st 2009
|
| 09.00-09.30
|
Lecture
Chairperson: Grigoris Simos (Greece)
Suicide among untreated and treated depressives: The role of compliance, drug-resistance and underlying bipolarity
Zoltan Rihmer (Hungary)
|
| 09.30-11.00
|
Symposium
Treatment guidance/guidelines: history, concept, need, theoretical support
Chairpersons: Norman Sartorius (Switzerland) and Wolfgang Gaebel (Germany)
Introduction to treatment guidance
Norman Sartorius (Switzerland)
What makes good guidelines?
Wolfgang Gaebel (Germany)
NICE guidelines
Stephen Pilling (UK)
Guidelines for research: requirements and challenges
Silvana Galderisi (Italy)
Concluding remarks
Norman Sartorius (Switzerland)
The symposium is organized by the European Psychiatric Association
|
| 11.00-12.30
|
Symposium
Future trends in social psychiatry
Chairpersons: Julio Arboleda Florez (Canada) and Driss Moussaoui (Morocco)
Impact of globalisation on social psychiatry
Marianne Kastrup (Denmark)
Social Darvinism and psychopathology
Andreas Erfurth (Austria)
What research is needed in social psychiatry?
Driss Moussaoui (Morocco)
Social rituals and onset of mental disorders
Aleksandar Janca (Australia)
The symposium is organized by the Euro-Mediterranean Network on Migration and Mental Health
|
| 12.30-13.00
|
Coffee break
|
| 13.00-14.30
|
SATELITE Symposium
Bipolar disorder: From clinical data to real life
Chairperson: Konstantinos N Fountoulakis (Greece)
The global effect of aripiprazole monotherapy in the spectrum of symptoms in bipolar disorder: A meta-analysis
Konstantinos N Fountoulakis (Greece)
Aripiprazole in Bipolar Disorder: Clinical Strategies to maximize efficacy and tolerability
Andrea Fagiolini (Italy)
The symposium is organized by Bristol Myers Squibb
|
| 14.30-15.30
|
Lunch Break
|
| 15.30-17.00
|
Open discussion on Mental Health Care (session in Greek)
Is organized by the WPA Section on Private Practice Psychiatry and the Network on Dialogue for Mental Health Care
|
| 17.00-17.30
|
Lecture
Chairperson: Lefteris Lykouras (Greece)
The neurobiology of subjective tolerability to antipsychotic medications in Schizophrenia - Is it also relevant to the genesis of comorbid addiction?
George Awad (Canada)
|
| 17.30-19.00
|
Symposium
Treatment guidance on bipolar disorder
Chairperson: Siegfried Kasper (Austria)
Treatment guidelines for acute mania
Jose Goigolea (Spain) and Eduard Vieta (Spain)
Treatment guidelines for acute bipolar depression
Konstantinos N. Fountoulakis (Greece)
Long-term treatment of bipolar disorder
John Cookson (UK)
How can guidelines help us in daily practice
Siegfried Kasper (Austria)
The symposium is organized by the European Psychiatric Association
|
| 19.00-19.30
|
Coffee break
|
| 19.30-20.00
|
Lecture
Chairperson: Alan Gelenberg (USA)
Integrating science and clinical practice in the understanding and treatment of mood disorders
Hagop Akiskal (USA)
The lecture is based on an educational grant by Alapis
|
| 20.00-21.30
|
SATELITE Symposium
Can we achieve early and long-term effective treatment of schizophrenia?
Chairpersons: Hans-Jürgen Möller (Germany) and Konstantinos N Fountoulakis (Greece)
Why treating early, treating well, and treating for life is important in schizophrenia
Rene Kahn (The Netherlands)
The need for efficient long-term neuroleptic treatment in schizophrenic patients and the place of long acting injectable antipsychotics".
Hans-Jürgen Möller (Germany)
The role of RLAI in early schizophrenia treatment: critical aspects regarding efficacy and safety
George Papageorgiou (Greece)
The symposium is organized by Janssen-Cilag
|
| 21:30
|
Awards ceremony
|
|
| Sunday November 22nd 2009
|
| 09.00-09.30
|
Lecture
Chairperson: Charalampos Touloumis (Greece)
Polypharmacy in schizophrenia - therapeutic option or a sign of despair?
Anastasios Konstantinidis (Austria)
|
| 09.30-11.00
|
Symposium
Ethics, Aesthetics and Psychopharmacology
Chairpersons: Luis Camara Pestana (Portugal) and Maria Luisa Figueira (Portugal)
New patients, new disorders, new drugs and the rise of prescriptions.
Luis Camara Pestana (Portugal)
Are depressive residual symptoms independent of treatments?
Maria Luisa Figueira (Portugal)
Psychopharmacology at the era of EMEA (European Medicines Agency)
Luis Camara Pestana (Portugal), Licinia Gananca (Portugal)
Medical care and long-term treatment of patients with schizophrenia: ethical concerns
Frederico Simoes do Couto (Portugal)
The symposium is organized by the Portuguese Association of Biological Psychiatry
|
| 11.00-12.30
|
Symposium
New Insights in Affective Temperaments and Bipolar Spectrum
Chairperson: Athanasios Koukopoulos (Italy)
Temperament and Major Depressive Disorder
Elie Karam (Lebanon)
Clinical approach of alcoholism through affective temperaments
Andreas Erfurth (Austria)
Cyclothymic temperament and/or Borderline Personality Disorder
Giulio Perugi (Italy)
Temperament and Schema-focused diagnosis in soft bipolarity
Elie Hantouche (France)
The symposium is organized by the European Bipolar Network
|
| 12.30-13.00
|
Coffee break
|
| 13.00-14.30
|
Symposium
Treatment of Alcohol and Substance Use Disorders in People with Hepatitis C.
Chairperson: Peter Hauser (USA)
Brief Interventions for Reducing Drinking in Veterans with Hepatitis C.
Bret Fuller (USA)
Medication Treatment of Alcohol Use Disorders in Veterans with Hepatitis C.
Peter Hauser (USA)
Chronic Pain and Substance Use in Patients with Hepatitis C.
Ben Morasco (USA)
|
| 14.30-15.00
|
Lecture
Chairperson: Panagiotis Grigoriou (Greece)
Cross-Cultural Psychopharmacology: A Review
Edmond H. Pi (USA)
|
| 15:00-15.30
|
Lecture
Chairperson: Armen Soghoyan (Armenia)
Specific inhibition of adenylyl-cyclase isoform 5 by mood stabilizers may be related to their mechanism of action
Galila Agam (Israel)
|
| 15.30
|
Closing ceremony
|
Home
Contact
AWARDS
SCIENTIFIC PROGRAM